The company initiated its next development program for etripamil, starting a Phase III AFib-RVR trial. “We have initiated our Phase III trial for atrial fibrillation with rapid ventricular rate or ...

The company reported Q1 “GAAP net income was $40.8 million and adjusted EBITDA was $76.7 million,” and Martini said Ironwood “ended the first quarter of 2026 with $220.5 million of cash and cash ...

CNBC Select compared over a dozen lenders based on fees, terms, eligibility requirements and more to determine the best ...

Analysts have made only a slight adjustment to their fair value view on PTC Therapeutics, with the target moving from $87.87 to $88.07 per share. That small change reflects a mix of bullish and ...

Depending on your current financial situation and how much your dream item costs, you may be able to benefit from a card's 0% ...

This month, banks and financial institutions are offering sign-up bonuses of $400 all the way to $80,000. But there are often requirements you must meet to reach the highest cash bonus, such as being ...

Soaring gold prices, viral panning influencers, macho gold-mining reality shows, and Trump’s gold obsession have ignited a ...

aTyr Pharma (NASDAQ:ATYR) said it plans to conduct a new Phase III trial of efzofitimod in pulmonary sarcoidosis after ...

American Well Corporation (NYSE: AMWL) Q1 2026 Earnings Call Transcript May 6, 2026 ...

CFO transition -- Abhishek Jain announced retirement, with Nathan Smith appointed as incoming CFO effective Aug. 7.

Q1 2026 Management view "In the first quarter, we continued to execute our strategy to evolve MannKind to a diversified company positioned to deliver sustained long-term growth," said CEO Michael ...